GENOTROPIN (somatropin) for injection is a white, lyophilized powder in a single-patient-use or single-dose, two-chamber cartridge intended for subcutaneous injection after reconstitution. The front chamber contains somatropin and the rear chamber contains the diluent.
GENOTROPIN lyophilized powder is available in the following packages:
5 mg single‑patient‑use two-chamber cartridge (with preservative)
12 mg single‑patient‑use two-chamber cartridge (with preservative)
GENOTROPIN MINIQUICK, a single-dose Growth Hormone Delivery Device containing a two-chamber cartridge of GENOTROPIN (without preservative)
GENOTROPIN MINIQUICK is available in the following strengths, each in a package of 7:
Strength | NDC Number |
0.2 mg | NDC 0013-2649-02 |
0.4 mg | NDC 0013-2650-02 |
0.6 mg | NDC 0013-2651-02 |
0.8 mg | NDC 0013-2652-02 |
1 mg | NDC 0013-2653-02 |
1.2 mg | NDC 0013-2654-02 |
1.4 mg | NDC 0013-2655-02 |
1.6 mg | NDC 0013-2656-02 |
1.8 mg | NDC 0013-2657-02 |
2 mg | NDC 0013-2658-02 |
The 5 mg and 12 mg GENOTROPIN single-patient-use cartridges:
The 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1.0 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8 mg and 2 mg single-dose Growth Hormone Delivery Devices containing a two-chamber cartridge (GENOTROPIN MINIQUICK):
GENOTROPIN (somatropin) for injection is a white, lyophilized powder in a single-patient-use or single-dose, two-chamber cartridge intended for subcutaneous injection after reconstitution. The front chamber contains somatropin and the rear chamber contains the diluent.
GENOTROPIN lyophilized powder is available in the following packages:
5 mg single‑patient‑use two-chamber cartridge (with preservative)
12 mg single‑patient‑use two-chamber cartridge (with preservative)
GENOTROPIN MINIQUICK, a single-dose Growth Hormone Delivery Device containing a two-chamber cartridge of GENOTROPIN (without preservative)
GENOTROPIN MINIQUICK is available in the following strengths, each in a package of 7:
Strength | NDC Number |
0.2 mg | NDC 0013-2649-02 |
0.4 mg | NDC 0013-2650-02 |
0.6 mg | NDC 0013-2651-02 |
0.8 mg | NDC 0013-2652-02 |
1 mg | NDC 0013-2653-02 |
1.2 mg | NDC 0013-2654-02 |
1.4 mg | NDC 0013-2655-02 |
1.6 mg | NDC 0013-2656-02 |
1.8 mg | NDC 0013-2657-02 |
2 mg | NDC 0013-2658-02 |
The 5 mg and 12 mg GENOTROPIN single-patient-use cartridges:
The 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1.0 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8 mg and 2 mg single-dose Growth Hormone Delivery Devices containing a two-chamber cartridge (GENOTROPIN MINIQUICK):
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.